4-(4-(2-(2-Chlorophenoxy)acetyl)piperazin-1-yl)benzoic acid

ID: ALA4483657

PubChem CID: 155540492

Max Phase: Preclinical

Molecular Formula: C19H19ClN2O4

Molecular Weight: 374.82

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1ccc(N2CCN(C(=O)COc3ccccc3Cl)CC2)cc1

Standard InChI:  InChI=1S/C19H19ClN2O4/c20-16-3-1-2-4-17(16)26-13-18(23)22-11-9-21(10-12-22)15-7-5-14(6-8-15)19(24)25/h1-8H,9-13H2,(H,24,25)

Standard InChI Key:  BJHKBHQSJNJBBD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   12.5866  -19.6868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5855  -20.5064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2935  -20.9153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0032  -20.5059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0004  -19.6832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2917  -19.2780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7115  -20.9134    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7086  -21.7307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4128  -22.1381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1223  -21.7319    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1230  -20.9138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4142  -20.5018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8291  -22.1421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8273  -22.9593    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.5377  -21.7350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2445  -22.1452    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9531  -21.7382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6590  -22.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3671  -21.7457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3694  -20.9276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6576  -20.5176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9524  -20.9263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8788  -19.2784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8786  -18.4612    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1712  -19.6872    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.6552  -22.9692    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  1 23  1  0
 23 24  2  0
 23 25  1  0
 18 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4483657

    ---

Associated Targets(Human)

ENPP2 Tchem Autotaxin (2645 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 374.82Molecular Weight (Monoisotopic): 374.1033AlogP: 2.77#Rotatable Bonds: 5
Polar Surface Area: 70.08Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.71CX Basic pKa: 1.40CX LogP: 2.93CX LogD: 0.30
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.87Np Likeness Score: -1.51

References

1. Ragle LE, Palanisamy DJ, Joe MJ, Stein RS, Norman DD, Tigyi G, Baker DL, Parrill AL..  (2016)  Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition.,  24  (19): [PMID:27544588] [10.1016/j.bmc.2016.08.004]

Source